본문 바로가기
KERD
논문KCI 등재후보

Intensive blood pressure lowering: a practical review

편욱범|Camafort Miguel|Redón Josep|Coca Antonio
대한고혈압학회 (The Korean Society of Hypertension)|2020.12|Clinical Hypertension|제26권 제4호|pp. 28-35|DOI 10.1186/s40885-020-00153-z

4

조회

0

다운로드

4

인용

0

참고문헌

키워드

ObesityAgeingIschemic heart diseaseChronic kidney diseaseHeart failureDiabetes mellitus type 2Intensive blood pressure loweringcardiovascular riskAmbulatory blood pressure measurement

초록

According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower BP goals. However, taking into account the relevance of correct BP measurement, estimates of the benefits versus the harm should be based on reliable office BP measurements and home BP measurements.There is still debate about which BP goals are optimal in reducing morbidity and mortality in uncomplicated hypertensives and in those with associated comorbidities. In recent years, trials and meta-analyses have assessed intensive BP lowering, with some success. However, a careful examination of the results shows that current data are not easily applicable to the general hypertensive population.This article reviews the evidence on and controversies about intensive BP lowering in general and in specific clinical situations, and the importance of obtaining reliable BP readings in patients with hypertension and comorbidities.

Abstract

According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower BP goals. However, taking into account the relevance of correct BP measurement, estimates of the benefits versus the harm should be based on reliable office BP measurements and home BP measurements.There is still debate about which BP goals are optimal in reducing morbidity and mortality in uncomplicated hypertensives and in those with associated comorbidities. In recent years, trials and meta-analyses have assessed intensive BP lowering, with some success. However, a careful examination of the results shows that current data are not easily applicable to the general hypertensive population.This article reviews the evidence on and controversies about intensive BP lowering in general and in specific clinical situations, and the importance of obtaining reliable BP readings in patients with hypertension and comorbidities.

참고문헌 (39)

  1. Williams B, "Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension, 27(6)", pp.314~340 (2018), Blood Press
  2. Mills KT, "Global disparities of hypertension prevalence and control : a systematic analysis of population-based studies from 90 countries", Circulation, 134(6), pp.441~450 (2016)
  3. Lewington S, "Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61prospective studies", Lancet, 360(9349), pp.1903~1913 (2002)
  4. Rapsomaniki E, "Blood pressure and incidence of twelve cardiovascular diseases : lifetime risks, healthy life-years lost, and age-specific associations in 1, 25million people", Lancet, 383(9932), pp.1899~1911 (2014)
  5. Singh GM, "The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes : a pooled analysis", PLoS One, 8(7), pp.e65174~ (2013)
  6. Lawes CM, "Blood pressure and cardiovascular disease in the Asia Pacific region", J Hypertens, 21(4), pp.707~716 (2003)
  7. Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
  8. So Mi Jemma Cho, "Differential Control Rate of Systolic and Diastolic Blood Pressure among Korean Adults with Hypertension: the Sixth Korean National Health and Nutrition Examination Survey, 2013–2015 (KNHANES VI)", Korean Circulation Journal, 49(11), pp.1035~1048 (2019), 대한심장학회[DOI]
  9. Bernard M.Y. Cheung, "A 2020 Vision of Hypertension", Korean Circulation Journal, 50(6), pp.469~475 (2020), 대한심장학회[DOI]
  10. Hae-Young Lee, "2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension", Clinical Hypertension, 25(4), pp.51~74 (2019), 대한고혈압학회[DOI]
  11. Jinho Shin, "Updated Reasons and Clinical Implications of New Korean Hypertension Guidelines for Cardiologists", Korean Circulation Journal, 50(6), pp.476~484 (2020), 대한심장학회[DOI]
  12. Ju-Seung Kwun, "Potential impact of 2018 Korean Society of Hypertension guidelines on Korean population: a population-based cohort study", Clinical Hypertension, 26(2), pp.22~29 (2020), 대한고혈압학회[DOI]
  13. Bavishi C, "Outcomes of intensive blood pressure lowering in older hypertensive patients", J Am Coll Cardiol, 69(5), pp.486~493 (2017)
  14. Byrne C, "Intensive blood pressure lowering in different age categories:insights from the Systolic Blood Pressure Intervention Trial", Eur Heart J Cardiovasc Pharmacother, pp.pvz050~ (2019)[DOI]
  15. Cushman WC, "SPRINT trial results : latest news in hypertension management", Hypertension, 67(2), pp.263~265 (2016)
  16. Williamson JD, "intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial", JAMA, 315(24), pp.2673~2682 (2016)
  17. Rockwood K, "A global clinical measure of fitness and frailty in elderly people", CMAJ, 173(5), pp.489~495 (2005)
  18. Russo G, "Impact of SPRINT results on hypertension guidelines : implications for"frail"elderly patients", J Hum Hypertens, 32, pp.633~638 (2018)
  19. Oxlund CS, "Body mass index, intensive blood pressure management, and cardiovascular events in the SPRINT trial", Am J Med, 132(7), pp.840~846 (2019)
  20. Zhang L, "Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score : A post hoc analysis of the Systolic Blood Pressure Intervention Trial(SPRINT)", J Clin Hypertens(Greenwich), 21(12), pp.1813~1820 (2019)
  21. Rahman F, "Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus", Hypertension, 73(6), pp.1291~1299 (2019)
  22. Wang J, "Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2diabetic patients : a meta-analysis", PLoS One, 14(4), pp.e0215362~ (2019)
  23. Kamishima K, "Relationships between blood pressure lowering therapy and cardiovascular events in hypertensive patients with coronary artery disease and type 2 diabetes mellitus : the HIJ-CREATE sub-study", Diabetes Res Clin Pract, 149, pp.69~77 (2019)
  24. Roumie CL, "Blood pressure control and the association with diabetes mellitus incidence : results from SPRINT randomized trial", Hypertension, 75(2), pp.331~338 (2020)
  25. Cheung AK, "Effects of Intensive BP Control in CKD", J Am Soc Nephrol, 28(9), pp.2812~2823 (2017)
  26. Agarwal A, "Effect of baseline kidney function on the risk of recurrent stroke and on effects of intensive blood pressure control in patients with previous lacunar stroke : a post hoc analysis of the SPS3 trial(secondary prevention of small subcortical strokes)", J Am Heart Assoc, 8, pp.e013098~ (2019)
  27. Collard D, "Initial estimated glomerular filtration rate decline and longterm renal function during intensive antihypertensive therapy : a post hoc analysis of the SPRINT and ACCORD-BP randomized controlled trials", Hypertension, 75(5), pp.1205~1212 (2020)
  28. Malhotra R, "Effects of intensive blood pressure lowering on kidney tubule injury in CKD : a longitudinal subgroup analysis in SPRINT", Am J Kidney Dis, 73(1), pp.21~30 (2019)
  29. Xie X, "Effects of intensive blood pressure lowering on cardiovascular and renal outcomes : updated systematic review and meta-analysis", Lancet, 387(10017), pp.435~443 (2016)
  30. Messerli FH, "Dogma disputed : can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous", Ann Intern Med, 144(12), pp.884~893 (2006)
  31. SPRINT Research Group, "A randomized trial of intensive versus standard bloodpressure control", N Engl J Med, 373(22), pp.2103~2116 (2015)
  32. Benavente OR, "Blood-pressure targets in patients with recent lacunar stroke : the SPS3 randomised trial", Lancet, 382, pp.507~515 (2013)
  33. Katsanos AH, "Blood pressure reduction and secondary stroke prevention : a systematic review and meta-regression analysis of randomized clinical trials", Hypertension, 69(1), pp.171~179 (2017)
  34. Zhang Y, "Effect of intensive lowering of systolic blood pressure treatment on heart failure events : a meta-analysis of randomized controlled studies", J Hum Hypertens, 33(9), pp.648~657 (2019)
  35. Upadhya B, "Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial", Circ Heart Fail, 10(4), pp.e003613~ (2017)
  36. Kario K, "Morning home blood pressure is a strong predictor of coronary artery disease the HONEST study", J Am Coll Cardiol, 67(13), pp.1519~1527 (2016)
  37. Asayama K, "Comparison of blood pressure values-self-measured at home, measured at an unattended office, and measured at a conventional attended office", Hypertens Res, 42(11), pp.1726~1737 (2019)
  38. Höller J, "The impact of measurement methods on office blood pressure and Management of Hypertension in general practice", High Blood Press Cardiovasc Prev, 26(6), pp.483~491 (2019)
  39. Chrubasik S, "Comparison of different methods of blood pressure measurements", Blood Press Monit, 12(3), pp.157~166 (2007)

관련 논문AI추천

Blood Pressure Variability and Its Management in Hypertensive Patients최희정대한가정의학회 · Korean Journal of Family Medicine2012 · 제33권 제6호Role of home blood pressure monitoring in resistant hypertension김혜미, 신진호대한고혈압학회 · Clinical Hypertension2023 · 제29권 Current status and therapeutic considerations of hypertension in the elderly김광일, 이주희, 조명찬대한내과학회 · The Korean Journal of Internal Medicine2019 · 제34권 제4호Optimizing systolic blood pressure targets for elderly hypertensive patients: a meta-analysis of mortality, cardiovascular outcomes, and adverse eventsIhm Sang-Hyun, Lee Hae-Young, Park Sungjoon, Shin Ein-Soon대한고혈압학회 · Clinical Hypertension2025 · 제31권 Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure박성하대한내과학회 · The Korean Journal of Internal Medicine2019 · 제34권 제1호A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective김광일, 신진호대한고혈압학회 · Clinical Hypertension2022 · 제28권

이 간행물의 다른 논문 (11건)

Serum adipocytokines and adiposity as predictive indices of preeclampsiaNanga Salifu, Alidu Huseini, Bawah Ahmed Tijani, Yeboah Francis Agyemang, Ngala Robert A.pp. 8-18Prevalence and determinants of self-reported high blood pressure among women of reproductive age in Benin: a population-based studyBarrow Amadou, Ekholuenetale Michaelpp. 8-16The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigmsMcLachlan Craig Stevenpp. 17-19High serum uric acid within the normal range is a useful predictor of hypertension among Japanese community-dwelling elderly womenKumagi Teru, Ninomiya Daisuke, Asuka Kikuchi, Akase Taichi, Kawamoto Ryuichipp. 19-27Association of MYH9-rs3752462 polymorphisms with chronic kidney disease among clinically diagnosed hypertensive patients: a case-control study in a Ghanaian populationOwiredu Eddie-Williams, Owiredu William K. B. A., Appiah Michael, Obirikorang Christian, Adu Evans Asamoah, Boima Vincent, Amos-Abanyie Ernestine Kubi, Akyaw Priscilla Abena, Acheampong Emmanuelpp. 20-28
원문 보기